The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 575-583

Bentham Science Publishers

Access to resources Recommend Favorite

Specificity of Effector Mechanisms in Syngeneic Graft-vs-Host Disease: Recognition of the MHC Class II Invariant Chain Peptide (CLIP)

By Hess A.   Thoburn C.   Bright E.   Horwitz L.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 725-727

Elsevier

Access to resources Recommend Favorite

Antigen presentation in graft-vs-host disease

By Shlomchik W.D.  

Experimental Hematology, Vol. 31, Iss. 12, 2003-12 ,pp. : 1187-1197

Elsevier

Access to resources Recommend Favorite

Pathogenic specificity of effector T lymphocytes in syngeneic graft-versus-host disease

By Thoburn C.   Chen W.   Horwitz L.   Hess A.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 684-686

Elsevier

Access to resources Recommend Favorite

A biased V 24 + T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease

By Demoulins T.   Gachelin G.   Bequet D.   Dormont D.  

Immunology Letters, Vol. 90, Iss. 2, 2003-12 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite